1. (a) A therapy management contract shall apply only to conditions for which protocols have been agreed to by an authorized prescriber and a licensed pharmacist in accordance with the regulations adopted under this subtitle.

2. (b) A therapy management contract shall include:

   1. (1) A statement that none of the parties involved in the therapy management contract have been coerced, given economic incentives, excluding normal reimbursement for services rendered, or involuntarily required to participate;

   2. (2) Notice to the patient indicating:

      1. (i) That the patient may terminate the therapy management contract at any time; and
      2. (ii) The procedure by which the patient may terminate the therapy management contract;
   3. (3) A procedure for periodic review by the authorized prescriber, of the drugs modified pursuant to the agreement or changed with the consent of the authorized prescriber; and
   4. (4) Reference to a protocol, which will be provided to the patient on request.

3. (c)

   1. (1) A therapy management contract may be entered into in writing or orally.
   2. (2) If a therapy management contract is entered into orally, the parties to the therapy management contract shall reduce the agreement to writing within 30 days after entering into the therapy management contract.
   3. (3) A therapy management contract may be in electronic form.
4. (d) Any party to the therapy management contract may terminate the contract at any time.
5. (e) The Board may assess a fee, as established in regulation, for approval of a pharmacist to enter into a prescriber-pharmacist agreement.

Added by Acts 2002, c. 249, § 1, eff. Oct. 1, 2002. Amended by Acts 2003, c. 21, § 1, eff. April 8, 2003; Acts 2003, c. 252, § 10, eff. July 1, 2003; Acts 2012, c. 658, § 1, eff. July 1, 2012; Acts 2015, c. 269, § 1, eff. Oct. 1, 2015; Acts 2023, c. 399, § 1, eff. Oct. 1, 2023.